EPZ015666 |
EPZ015666 : Inhibitor of PRMT5
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| PRMT5 |
|
|
Inhibitor
300 nM - 2.5 uM
Selectivity
In Vitro Selectivity Assessment
Potency Assay Off-Target:
No inhibition of 20 Protein methyltransferases at 50 uM (PRMT8, PRMT1, PRMT3, PRMT6, PRMT7, CARM1, D ...
Potency Cellular
In Vitro
PRMT5
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/acsmedchemlett.5b00380
In Vivo Validations
Mouse
Dose: 10 mg/kg, 2 mg/kg (IV)
Route of delivery:
Oral
Plasma half life:
1.62 hours (IV)
Systemic clearance:
30.0 mL/min/kg (IV)
Organ of interest (O):
xenograft
Target engagement assay:
In the SDMA ELISA, Z-138 xenograft tumors collected on day 21 showed dose-dependent changes of >40% and >95% inhibition (>48% and >87% for Maver-1 tumors at day 21; >66% and >95% for Granta-519 tumors at day 18) of the methyl mark achieved at the lowest dose and highest dose, respectively.
DOI Reference: 10.1021/acsmedchemlett.5b00380
Negative Control Compounds
Chemical Information
| Molecular Formula | C20H25N5O3 |
| SMILEs | O=C(NC[C@H](O)CN1CCc2ccccc2C1)c1cc(NC2COC2)ncn1 |
| InChI | InChI=1S/C20H25N5O3/c26-17(10-25-6-5-14-3-1-2-4-15(14)9-25)8-21-20(27)18-7-19(23-13-22-18)24-16-11-28-12-16/h1-4,7,13,16-17,26H,5-6,8-12H2,(H,21,27)(H,22,23,24)/t17-/m0/s1 |
| Molecular weight | 383.20 Da |
| AlogP | 0.4362999999999995 |
| HBond acceptors | 8 |
| HBond donors | 3 |
| Atoms | 53 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.